Hamel Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
HPC
GWA
KCM
HCM
SIC
RW
KAS
WIC
Hamel Associates's IBDS Position: Q2 2026 in Review
Hamel Associates reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 2.5% in Q2 2026, selling an estimated $162K and leaving 265,974 shares worth $6.44M. The position accounts for 1.78% of the portfolio, ranked #21.
Hamel Associates first reported a position in IBDS in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.12M in Q4 2024. 212 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.
- Hamel Associates held 265,974 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $6.44M as of Q2 2026.
- Hamel Associates sold 6,702 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $162K.
- iShares iBonds Dec 2027 Term Corporate ETF made up 1.78% of Hamel Associates's portfolio in Q2 2026, its #21 holding.
- Hamel Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
- Hamel Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $8.12M in Q4 2024.
- 212 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.
Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.